COSMOS Pharmaceutical Statistics

Total Valuation

COSMOS Pharmaceutical has a market cap or net worth of JPY 507.72 billion. The enterprise value is 483.12 billion.

Market Cap	507.72B
Enterprise Value	483.12B

Important Dates

The next estimated earnings date is Friday, January 10, 2025.

Earnings Date	Jan 10, 2025
Ex-Dividend Date	Nov 28, 2024

Share Statistics

COSMOS Pharmaceutical has 79.26 million shares outstanding. The number of shares has increased by 0.07% in one year.

Current Share Class	n/a
Shares Outstanding	79.26M
Shares Change (YoY)	+0.07%
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	38.76%
Owned by Institutions (%)	25.32%
Float	43.66M

Valuation Ratios

The trailing PE ratio is 19.46 and the forward PE ratio is 19.37. COSMOS Pharmaceutical's PEG ratio is 2.82.

PE Ratio	19.46
Forward PE	19.37
PS Ratio	0.52
PB Ratio	2.14
P/TBV Ratio	2.14
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	2.82

Financial Ratio History

Enterprise Valuation

EV / Earnings	18.52
EV / Sales	0.49
EV / EBITDA	n/a
EV / EBIT	14.36
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.72, with a Debt / Equity ratio of 0.11.

Current Ratio	0.72
Quick Ratio	0.24
Debt / Equity	0.11
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	258.75

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	n/a
Revenue Per Employee	178.73M
Profits Per Employee	4.73M
Employee Count	5,512
Asset Turnover	2.14
Inventory Turnover	9.47

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.71% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-17.71%
50-Day Moving Average	7,206.24
200-Day Moving Average	6,952.42
Relative Strength Index (RSI)	26.06
Average Volume (20 Days)	380,345

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, COSMOS Pharmaceutical had revenue of JPY 985.18 billion and earned 26.09 billion in profits. Earnings per share was 329.18.

Revenue	985.18B
Gross Profit	195.86B
Operating Income	33.64B
Pretax Income	36.15B
Net Income	26.09B
EBITDA	n/a
EBIT	33.64B
Earnings Per Share (EPS)	329.18

Full Income Statement

Balance Sheet

The company has 51.42 billion in cash and 26.82 billion in debt, giving a net cash position of 24.60 billion or 310.38 per share.

Cash & Cash Equivalents	51.42B
Total Debt	26.82B
Net Cash	24.60B
Net Cash Per Share	310.38
Equity (Book Value)	237.20B
Book Value Per Share	2,992.83
Working Capital	-60.43B

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 19.88%, with operating and profit margins of 3.41% and 2.65%.

Gross Margin	19.88%
Operating Margin	3.41%
Pretax Margin	3.67%
Profit Margin	2.65%
EBITDA Margin	n/a
EBIT Margin	3.41%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 65.00, which amounts to a dividend yield of 1.01%.

Dividend Per Share	65.00
Dividend Yield	1.01%
Dividend Growth (YoY)	6.38%
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-0.07%
Shareholder Yield	0.94%
Earnings Yield	5.14%
FCF Yield	n/a

Dividend Details

Stock Splits

The last stock split was on August 29, 2024. It was a forward split with a ratio of 2.

Last Split Date	Aug 29, 2024
Split Type	Forward
Split Ratio	2

Scores

COSMOS Pharmaceutical has an Altman Z-Score of 4.17.

Altman Z-Score	4.17
Piotroski F-Score	n/a